Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Should I Buy Wetour Weto Stock Now Price At 0.51 Up 8.49 20260410 Fig Q4 2025 Earnings Figma Inc. Beats Eps Estimates With 0.08 Vs 0.0662 Forecast 20260403 Is Amfin Group Afgb Stock Breaking Resistance Price At 20.69 Up 0.63 20260406 Is Core Labs Clb Stock Showing Strength Price At 16.32 Down 0.06 20260406 Should I Buy Martin Mlm Stock Today Price At 597.31 Up 0.02 20260406 Why Microchip MCHP ability to execute stands out Trend Weakens 20260508 RBC RBC Stock Is It a Smart Buy Trend Strengthens 20260418 WSO Watsco Inc shares rise nearly 2 percent despite posting a wider than expected Q4 2025 EPS miss The industry tailwinds powering NewtekOne NEWT growth Eye on Rally 20260508 MGPI MGP Ingredients posts 229 percent Q4 2025 EPS beat shares gain 111 percent despite year over year revenue decline Johnson Johnson JNJ Oracle Corporation ORCL ShortTerm Price Momentum Masks Underlying Fundamental Risks NextCure NXTC Stock Rejected Order Smart Money Exits 20260424 Synthetic GJT Stock Analysis Earnings Report Chevron Corp CVX Positioned for Upside Amid Extended Iran Blockade Talks and Tightening Global Crude Markets SATS EchoStar Corporation posts vastly wider Q4 2025 loss than analyst forecasts shares drop 331 percent on negative investor sentiment MANE Veradermics Incorporated shares decline 175 on widened loss zero revenue as pipeline costs mount The surprise hidden in ICF International ICFI last earnings report ICF International Posts 34 EPS Miss Vs Consensus IBRX ImmunityBio reports narrower than expected Q4 2025 loss shares post small gain in todays trading UK Economy Surprises with 03 Growth in March Amid Geopolitical Tensions Iran War Fallout UK Businesses Halt Investment and Hiring as Costs Surge Survey Warns Spectrum SPB Q1 2026 Beat Revenue NA EPS Exceeds by Significant How Dropbox Makes Remote Work a Competitive Advantage as Rivals Return to Office Avient AVNT Q1 2026 Results Top Views on Strong Revenue Bain SpecFin BCSF Stock Down 165 Support Test at 1248 20260518 Team TISI Earnings Outlook Key Metrics for Q1 2026 TotalEnergies SE TTE Steady at 9188 Awaiting Next Catalyst 20260515 SpaceX IPO Filing Reveals Planetary Ambitions Asteroid Mining and a New Generation of Billionaires OpenAI Moves Toward Confidential IPO Filing Potential Valuation Up to 1 Trillion Actinium ATNM Delivers Q1 2026 Beat EPS 018 vs 024 Expected Dropboxs Fully Remote Model Strengthens Recruitment and Retention as RTO Mandates Rise Michael Saylor Says Tokenization May Reshape Credit Markets Challenging Traditional Banking Standard Chartered Plans Significant Reduction in Corporate Functions Roles Sets Higher Profitability Targets UKs FTSE 100 Breaks FourWeek Losing Streak as Slowing Inflation Eases Rate Hike Fears SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags AEHL Q3 2012 Earnings Strong EPS Beat Overshadowed by Sharp Stock Decline Vivani Medical VANI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction KAPA Q1 2026 Earnings EPS Misses Estimates as Development Expenses Weigh YPF Q4 2025 Earnings Massive Reported Loss Despite Positive Stock Movement INTG Q1 2026 Earnings Positive EPS of 071 Drives Stock Gain Mountain Lake Acquisition Corp II Units MLAAU Holds Steady at 1035 as Trading Remains Muted DiaMedica Therapeutics DMAC Gains 4 as Stock Approaches Key Resistance Level Nexstar Media Group NXST Edges Lower Amid Cautious Trading Support and Resistance Levels in Focus Concentrix CNXC Stock Rejected Order 135 20260418 PMTRU Perimeter reports quarterly results with no earnings as acquisition search continues stock unchanged Adamas Pref ADAMN Stock Next Quarter Breakout Watch 20260415 SLAI SOLAI Limited American Depositary Shares each representing 100 rises 10 percent after Q4 2024 earnings despite negative EPS The numbers behind Shift4 Payments FOUR stock nobody talks about 926 20260507 NAKA Nakamoto Inc climbs 378 percent on investor optimism despite weak Q4 2025 earnings and steep YoY revenue decline Is Journey Med DERM stock worth building a position in Q4 2025 Profit Exceeds Views